Dr Stephen-John Sammut, first author on the study and leader of the Cancer Dynamics Group at the ICR, said: “The computational tool we have developed will allow us to zoom in and identify the B cells that have recognised cancer cells, as well as the antibodies they are producing. This will allow us to develop anti-cancer antibody treatments similar to the ones the B cells produce, which can then be given as a personalised treatment to boost the immune system’s response against breast cancer that has spread.”
Birdily
Related